Interestingly, we found differential regulation of this protein between the groups analyzed: Compared to healthy controls, we observed that MAGI2 abundance was increased in 2/5 patients diagnosed with MCD, while a statistically significant downregulation could be demonstrated in cases of FSGS (Fig. 12 B). This evidence concerns the gene MAGI2 and focal segmental glomerulosclerosis.